News

Published on 18 Jun 2024 on Insider Monkey · via Yahoo Finance

Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy...


Article preview image

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Applied Therapeutics, Inc. (NASDAQ:APLT) stands against the other biotech penny stocks.

Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opportunities

In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities. Particularly biotech is anticipated to profit, despite the dangers of continuous mergers and acquisitions. Traders ought to exercise caution. With an 11.8% CAGR, the worldwide biotechnology market is expected to reach USD 4.25 trillion by 2033. It is expanding quickly. The U.S. market is projected to increase at an 11.90% CAGR to reach USD 763.82 billion by 2033 from its 2023 valuation of USD 246.18 billion. In 2023, the U.S. led North America in terms of revenue share.

NASDAQ.APLT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited...

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder...

Benzinga · via Yahoo Finance 19 Sep 2024

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has...

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, A...

Benzinga · via Yahoo Finance 19 Jul 2024

Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy...

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ...

Revenue: Reported at $190K for Q1 2024, significantly below estimates of $3.33M.Net Loss: Increas...

GuruFocus.com via Yahoo Finance 10 May 2024

Applied Therapeutics reveals Phase 3 data on heart drug By Investing.com

Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, is set to...

Investing.com 4 Apr 2024

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket By...

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

Investing.com 1 Apr 2024

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket -...

Shares of Doma Holdings Inc. DOMA rose sharply in today’s pre-market trading after the company e...

Benzinga 1 Apr 2024

Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower...

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on M...

Benzinga 1 Apr 2024

Applied Therapeutics gets extension of FDA review for rare disease drug

The U.S. FDA has delayed the review of Applied Therapeutics' NDA for rare drug disease candidate...

Seeking Alpha 28 Mar 2024

FDA extends review of Applied Therapeutics' Galactosemia drug

The U.S. Food and Drug Administration (FDA) has extended its review of the New Drug Application...

Investing.com 27 Mar 2024